
|Articles|June 1, 2003
Bimatoprost effective in patients with POAG, hypertension
Author(s)Chet Scerra
Fort Lauderdale, FL-Bimatoprost appears to have greater IOP-lowering effectiveness than travoprost in patients with primary open-angle glaucoma (POAG) or ocular hypertension, according to a small pilot study.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Nanoscope Therapeutics releases positive long-term safety results from EXTEND study
2
Ocular Therapeutix reaches target enrollment of 555 patients in SOL-R trial
3
Avisi Technologies releases positive 12-month data from VITA Trial
4
Selecting Anti-VEGF Therapies in Retinal Vascular Disease Management
5


















































.png)


